Leonardus H.T. van der Ploeg - Chief Scientific Officer, Rhythm Pharmaceuticals, Inc

As of June 3, 2019


Leonardus H.T. van der Ploeg Net Worth

  • Net worth is estimated to be at least $3.27M
  • Owns at least 42,339 units of Rhythm Pharmaceuticals, Inc stock
  • Sold an estimated value of $2.73M in the last year at Rhythm Pharmaceuticals, Inc

Leonardus H.T. van der Ploeg Trading

  • Largest purchase of shares was 28,200 units , worth over $174.24K on November 6, 2018
  • Largest sale of shares was 38,000 units , worth over $1.14M on November 6, 2018
  • In total has made about 7 transactions over a year
  • Usually trades in February, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Leonardus H.T. van der Ploeg Mailing Address

  • Mailing address is 101 Hammond Street Newton MA 02467 MA

Rhythm Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David P. Meeker, M.D. 2020 $262,308 - $918,500 $12,844,897 $207,958 $43,704 $13,358,867
Keith M. Gottesdiener, M.D. 2020 $142,906 - - $2,810,726 - $495,537 $3,449,169
Keith M. Gottesdiener, M.D. 2019 $525,934 - - $4,133,768 $277,340 - $4,937,042
Hunter C. Smith 2020 $416,118 $60,000 $132,000 $1,837,630 $209,595 $7,125 $2,530,468
Hunter C. Smith 2019 $396,992 - - $1,286,061 $153,224 $86,576 $1,922,853
Murray Stewart, D.M., F.R.C.P. 2020 $451,169 $60,000 $113,000 $1,555,420 $226,600 $7,125 $2,300,314
Jennifer Chien 2020 $45,577 $100,000 $100,000 $1,517,540 $49,375 - $1,712,492
Nithya Desikan 2020 $305,510 - $105,000 $1,533,841 - $104,620 $1,943,971
Nithya Desikan 2019 $379,063 - - $1,286,061 $145,117 - $1,810,241
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1649904/000110465921055591/tm212464-1_def14a.htm

Rhythm Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units bought on March 31, 2021 by David Meeker worth over $201.71K
  • In the last 4 years, insiders at Rhythm Pharmaceuticals, Inc sold an estimated value of $75.38M and bought an estimated value of $108.59M
  • The most active traders are Todd Foley, Director,  Keith M. Gottesdiener, CEO & President,  and Hunter C Smith, Chief Financial Officer
  • Insider trading is most common in June, with the busiest year in 2020

RHYTHM PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1